Sex differences in return to work for cancer survivors

February 1, 2013
Sex differences in return to work for cancer survivors
Significant differences have been identified in the return-to-work process for male and female cancer survivors, according to research published online Jan. 28 in the Journal of Clinical Oncology.

(HealthDay)—Significant differences have been identified in the return-to-work (RTW) process for male and female cancer survivors, according to research published online Jan. 28 in the Journal of Clinical Oncology.

Patricia Marino, Ph.D., of the Institut Paoli-Calmettes in Marseilles, France, and colleagues examined the effects of clinical, sociodemographic, and occupational factors on time to RTW for 801 employed cancer survivors younger than 58 years in the two years after .

The researchers identified in the RTW process. Married men returned to work faster than married women and older men had a delayed RTW versus older women (P = 0.19 and 0.13, respectively). For male survivors, the duration of sick leave was independent of the probability of returning to work, while for female survivors there was positive duration dependence. Clinical factors, including chemotherapy regimen, adverse effects experienced, and cancer severity, significantly delayed RTW for both men and women. RTW was also delayed for cancer survivors who invested more strongly in their personal lives or had a permanent work contract. Having a higher educational level accelerated the RTW.

"The results obtained show that the duration of sick leave is sex-specific," the authors write. "A better knowledge of the RTW process would enable physicians to identify patients with intervention needs more accurately, thus helping national implementation of more cost-effective strategies for managing ' RTW."

Explore further: Long-term cancer survivors struggle to keep regular work hours

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Long-term cancer survivors struggle to keep regular work hours

June 19, 2012
Long-term cancer survivors take sick leave more often than their disease-free colleagues, suggesting that they struggle at work despite their ability to work five years after diagnosis. These findings by Steffen Torp, from ...

Sexual orientation affects cancer survivorship

May 9, 2011
Gay men have a higher prevalence of cancer compared with heterosexual men, and lesbian and bisexual female cancer survivors report lower levels of health than heterosexual female cancer survivors. Those are the conclusions ...

Many breast cancer survivors worry about cancer returning

April 20, 2012
"Cancer worry" is the fear that cancer will return, said researchers at Moffitt Cancer Center who studied cancer worry among breast cancer survivors and published their findings in Psycho-Oncology. They found that even three ...

Recommended for you

Presurgical targeted therapy delays relapse of high-risk stage 3 melanoma

January 17, 2018
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at ...

Dulling cancer therapy's double-edged sword

January 17, 2018
Researchers have discovered that killing cancer cells can actually have the unintended effect of fueling the proliferation of residual, living cancer cells, ultimately leading to aggressive tumor progression.

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.